Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [3]
- Immunohistochemistry [5]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NBP1-81580 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NBP1-81580, RRID:AB_11023848
- Product name
- Rabbit Polyclonal RBM3 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified. Specificity of human RBM3 antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 ml
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references Generation of monospecific antibodies based on affinity capture of polyclonal antibodies.
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer.
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
Hjelm B, Forsström B, Igel U, Johannesson H, Stadler C, Lundberg E, Ponten F, Sjöberg A, Rockberg J, Schwenk JM, Nilsson P, Johansson C, Uhlén M
Protein science : a publication of the Protein Society 2011 Nov;20(11):1824-35
Protein science : a publication of the Protein Society 2011 Nov;20(11):1824-35
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer.
Hjelm B, Brennan DJ, Zendehrokh N, Eberhard J, Nodin B, Gaber A, Pontén F, Johannesson H, Smaragdi K, Frantz C, Hober S, Johnson LB, Påhlman S, Jirström K, Uhlen M
Proteomics. Clinical applications 2011 Dec;5(11-12):624-35
Proteomics. Clinical applications 2011 Dec;5(11-12):624-35
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
Jögi A, Brennan DJ, Rydén L, Magnusson K, Fernö M, Stål O, Borgquist S, Uhlen M, Landberg G, Påhlman S, Pontén F, Jirström K
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009 Dec;22(12):1564-74
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009 Dec;22(12):1564-74
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: RBM3 Antibody [NBP1-81580] - Analysis in mouse cell line NIH-3T3 and rat cell line NBT-II.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: RBM3 Antibody [NBP1-81580] - Analysis in U-251MG cells transfected with control siRNA, target specific siRNA probe #1 and #2. Remaining relative intensity is presented. Loading control: Anti-GAPDH.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: RBM3 Antibody [NBP1-81580] - Analysis in human cell line HeLa.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: RBM3 Antibody [NBP1-81580] - Staining of human skin shows moderate nuclear positivity in epidermal cells.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: RBM3 Antibody [NBP1-81580] - Staining of human kidney shows no nuclear positivity in cells in glomeruli as expected.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: RBM3 Antibody [NBP1-81580] - Staining of human colorectal cancer shows weak nuclear positivity in tumor cells.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: RBM3 Antibody [NBP1-81580] - Staining of human testis shows moderate nuclear positivity in cells in seminiferous ducts.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: RBM3 Antibody [NBP1-81580] - Staining of human breast cancer shows moderate nuclear positivity in tumor cells.